Mainline Biosciences (Shanghai) Co., Ltd
1 clinical trials · Sponsor
◉ Watch Mainline Biosciences (Shanghai) Co., Ltd
| Record | Firm | Date |
|---|---|---|
| Evaluating the Safety, Tolerability, and Preliminary Anti-tumor Activity of MB0151 in Adult Subjects With Advanced Solid Tumors Expressing Somatostatin Receptors (NCT06840821) | Mainline Biosciences (Shanghai) Co., Ltd | 2025-05-08 |
Track Mainline Biosciences (Shanghai) Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.